Ahmet Cingöz

8PUBLICATIONS
30CO-AUTHORS
Gene and molecular therapyPredictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Dec 04, 2025
Distinct transcription factor interactions drive HOXB13 activity in different stages of prostate cancer.

Betul Ersoy-Fazlioglu, Shreyas Lingadahalli, Umut Berkay Altintas

|Jun 29, 2025
Chromatin-focused genetic and chemical screens identify BRPF1 as a targetable vulnerability in Taxol-resistant triple-negative breast cancer.

Ozlem Yedier-Bayram, Ahmet Cingöz, Ebru Yilmaz

|Jul 28, 2020
TRAIL-conjugated silver nanoparticles sensitize glioblastoma cells to TRAIL by regulating CHK1 in the DNA repair pathway.

Ilknur Sur-Erdem, Kerem Muslu, Nareg Pınarbası

Pageof 2